Can a drop or lens stop Kids' eyesight from worsening?

NCT ID NCT06282848

Recruiting now Disease control Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares two approaches to control myopia (nearsightedness) in children aged 7 to 9: low-dose atropine eye drops and special glasses called DIMS lenses. Over 24 months, researchers will measure changes in vision and eye structure to see which treatment works better for different children. The goal is to find personalized ways to slow down how fast nearsightedness gets worse.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 0.05% atropine eye drops and DIMS (defocus incorporated multiple segments) spectacle lenses
What this could lead to: If successful, this could provide a clearer picture of which children benefit most from atropine drops or special glasses to slow down worsening nearsightedness.
What could go wrong: This is a small, early-stage study (80 children) that measures eye changes over 24 months. It may not prove long-term effectiveness or apply to all children. Atropine drops can cause light sensitivity or blurry near vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

School of Optometry, Hong Kong Polytechnic University
RECRUITING

Hong Kong, 00000, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.